Morgan Stanley Sop Hi A Genetics Sa Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Morgan Stanley holds 37,101 shares of SOPH stock, worth $115,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,101
Previous 47,196
21.39%
Holding current value
$115,755
Previous $172,000
34.3%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding SOPH
# of Institutions
42Shares Held
20.2MCall Options Held
1KPut Options Held
500-
Generation Investment Management LLP London, X06.79MShares$21.2 Million0.11% of portfolio
-
Banque Pictet & Cie Sa2.24MShares$7 Million0.05% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$6.98 Million0.07% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.2MShares$6.86 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$6.76 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $200M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...